Empliciti OverviewElotuzumab (brand name Empliciti, (Bristol-Myers Squibb and AbbVie), previously known as HuLuc63) is a humanized monoclonal antibody used in relapsed multiple myeloma. The package insert denotes its mechanism as a SLAMF7-directed (also known as CD 319) immunostimulatory antibody. Contents 1 Approvals and indications 1.1 Multiple myeloma 2 References 3 External links Approvals and indications Multiple myeloma In May 2014, it was granted "Break...
Read more Empliciti Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Elotuzumab
Recent Empliciti Forums:Be the first to start a discussion about this drug.
Possible Dosages for this and Related Drugs:
- Injection: 300mg, 400mg
NDC Database Records for Empliciti: (2 results)Sorted by National Drug Code
- 0003-2291 Empliciti 300 mg Intravenous Injection, Powder, Lyophilized, for Solution by E.r. Squibb & Sons, L.L.C.
- 0003-4522 Empliciti 400 mg Intravenous Injection, Powder, Lyophilized, for Solution by E.r. Squibb & Sons, L.L.C.